118 related articles for article (PubMed ID: 2779868)
1. FDA approves Eprex for anemia related to AIDS.
Nurse Pract; 1989 Sep; 14(9):6. PubMed ID: 2779868
[No Abstract] [Full Text] [Related]
2. Eprex approved for anemia in AIDS patients.
Oncology (Williston Park); 1989 Sep; 3(9):79. PubMed ID: 2641692
[No Abstract] [Full Text] [Related]
3. Erythropoietin for severe anemia in AIDS patients.
Am Fam Physician; 1989 Sep; 40(3):311. PubMed ID: 2773761
[No Abstract] [Full Text] [Related]
4. Erythropoietin therapy in AIDS.
Henry DH
Prog Clin Biol Res; 1990; 338():113-20. PubMed ID: 2189134
[No Abstract] [Full Text] [Related]
5. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
6. Epoetin alpha approved for anemic AIDS patients.
J Am Osteopath Assoc; 1991 Jun; 91(6):538. PubMed ID: 1874651
[No Abstract] [Full Text] [Related]
7. FDA approves Epoetin Alfa use for AZT patients.
Nephrol News Issues; 1991 Apr; 5(4):11. PubMed ID: 1961277
[No Abstract] [Full Text] [Related]
8. Recombinant human erythropoietin and the treatment of anemia in patients with AIDS or advanced ARC not receiving ZDV.
Henry DH; Jemsek JG; Levin AS; Levine JD; Levine RL; Abels RI; Nelson RA; Thompson D; Rudnick SA
J Acquir Immune Defic Syndr (1988); 1992; 5(8):847-8. PubMed ID: 1517970
[No Abstract] [Full Text] [Related]
9. [Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients].
Karwacki M; Ochocka M; Kubiak W
Przegl Epidemiol; 1994; 48(4):441-7. PubMed ID: 7597181
[TBL] [Abstract][Full Text] [Related]
10. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
Besarab A; McCrea JB
ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
[No Abstract] [Full Text] [Related]
11. Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine.
Lancaster DJ; Palte S; Ray D
J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):533-4. PubMed ID: 8483118
[No Abstract] [Full Text] [Related]
12. FDA notifications. FDA issues public health advisory about ESAs.
AIDS Alert; 2007 May; 22(5):57-8. PubMed ID: 17580370
[No Abstract] [Full Text] [Related]
13. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin for zidovudine-induced anemia.
N Engl J Med; 1990 Oct; 323(15):1069-70. PubMed ID: 2215568
[No Abstract] [Full Text] [Related]
15. Recombinant erythropoietin for zidovudine-induced anemia in AIDS.
Kuehl AK; Noormohamed SE
Ann Pharmacother; 1995; 29(7-8):778-9. PubMed ID: 8520096
[TBL] [Abstract][Full Text] [Related]
16. FDA sounds alert on anemia drugs.
Mitka M
JAMA; 2007 May; 297(17):1868-9. PubMed ID: 17473287
[No Abstract] [Full Text] [Related]
17. CERA: third-generation erythropoiesis-stimulating agent.
Topf JM
Expert Opin Pharmacother; 2008 Apr; 9(5):839-49. PubMed ID: 18345959
[TBL] [Abstract][Full Text] [Related]
18. The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome.
Garnick MB; Abels R; Rudnick SA
Contrib Nephrol; 1991; 88():282-92; discussion 293-4. PubMed ID: 2040191
[No Abstract] [Full Text] [Related]
19. FDA approves treatment IND protocol for use of erythropoietin product in AIDS.
Clin Pharm; 1989 Sep; 8(9):607. PubMed ID: 2791478
[No Abstract] [Full Text] [Related]
20. FDA approves new epoetin product: Roche unsure when it can market in United States.
Thompson CA
Am J Health Syst Pharm; 2008 Jan; 65(1):10. PubMed ID: 18159030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
